Mark Paul Lappe
Net Worth
Last updated:
What is Mark Paul Lappe net worth?
The estimated net worth of Mr. Mark Paul Lappe is at least $21,655,643 as of 16 Sep 2024. He owns shares worth $16,227,604 as insider, has earned $2,821,159 from insider trading and has received compensation worth at least $2,606,880 in Inhibrx Biosciences, Inc..
What is the salary of Mark Paul Lappe?
Mr. Mark Paul Lappe salary is $868,960 per year as Founder, Chairman, Pres & Chief Executive Officer in Inhibrx Biosciences, Inc..
How old is Mark Paul Lappe?
Mr. Mark Paul Lappe is 57 years old, born in 1968.
What stocks does Mark Paul Lappe currently own?
As insider, Mr. Mark Paul Lappe owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Inhibrx Biosciences, Inc. (INBX) | Founder, Chairman, Pres & Chief Executive Officer | 705,548 | $23 | $16,227,604 |
What does Inhibrx Biosciences, Inc. do?
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates includes INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 that is in phase 2 clinical trial for the treatment of unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 that is in phase 2 clinical trial for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head and neck cancer, gastric (GIST) and gastroesophageal adenocarcinoma (GEA) cancer, renal cell carcinoma, and urothelial (transitional) cell carcinoma. The company was incorporated in 2024 and is based in La Jolla, California.
Mark Paul Lappe insider trading
Inhibrx Biosciences, Inc.
Mr. Mark Paul Lappe has made 17 insider trades between 2022-2024, according to the Form 4 filled with the SEC. Most recently he purchased 13,037 units of INBX stock worth $223,324 on 16 Sep 2024.
The largest trade he's ever made was exercising 26,963 units of INBX stock on 12 Sep 2024. As of 16 Sep 2024 he still owns at least 705,548 units of INBX stock.
Inhibrx Biosciences key executives
Inhibrx Biosciences, Inc. executives and other stock owners filed with the SEC:
- Dr. Brendan P. Eckelman Ph.D. (46) Founder, Chief Scientific Officer & Executive Vice President of Corporation Strategy
- Dr. Klaus W. Wagner (52) Chief Medical Officer & Executive Vice President
- Mr. Mark Paul Lappe (57) Founder, Chairman, Pres & Chief Executive Officer